← Leaderboards
Jeffrey M. Pyne
Central Arkansas Veterans Hlthcare Sys
$1,624,634
Attributed
$1,624,634
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $346.7K · FY2005–24$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,624,634 · 3
VA$0 · 2
By mechanism
R01$1,332,634 · 1
R21$292,000 · 1
I01$0 · 1
I21$0 · 1
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Central Arkansas Veterans Hlthcare Sys
Same institution · by research overlap
- Alexei G Basnakian$3,611,011
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchBehavioral /Social Science Research TagDepressionHuman SubjectComorbidityRelapse /RecurrenceMental Disorder DiagnosisHospital UtilizationSign /SymptomPathologic ProcessQuality Of LifeDisease /Disorder OnsetMental HealthMental Health ServicesCaringBaseResearch PersonnelHealth PersonnelHealth Services ResearchInstrumentComplexDoctor Of PhilosophyHealthcareInterview
Grant awards (22)
Mental Health Clinician/Chaplain Collaboration (MC3): A Pilot Study$0
I21 · FY2024 · VA · contact PI
Development and Validation of a Perceived Access Measure$0
I01 · FY2020 · VA · contact PI
Development and Validation of a Perceived Access Measure$0
I01 · FY2018 · VA · contact PI
Development and Validation of a Perceived Access Measure$0
I01 · FY2018 · VA · contact PI
Development and Validation of a Perceived Access Measure$0
I01 · FY2018 · VA · contact PI
Development and Validation of a Perceived Access Measure$0
I01 · FY2018 · VA · contact PI
Development and Validation of a Perceived Access Measure$0
I01 · FY2014 · VA · contact PI
Cost-Effectiveness of Reducing Drug Treatment Barriers$329,872
R01 · FY2008 · DA · contact PI
Cost-Effectiveness of Reducing Drug Treatment Barriers$336,604
R01 · FY2007 · DA · contact PI
Cost-Effectiveness of Reducing Drug Treatment Barriers$346,658
R01 · FY2006 · DA · contact PI
Cost-Effectiveness of Reducing Drug Treatment Barriers$319,500
R01 · FY2005 · DA
QALYs for Depression: Whose Valuations to Use for CEA$146,000
R21 · FY2003 · MH
QALYs for Depression: Whose Valuations to Use for CEA$146,000
R21 · FY2002 · MH
RELATIONSHIP OF QUALITY OF WELL BEING AND ACUTE CHANGES IN DEPRESSION$0
M01 · FY2002 · RR
RELATIONSHIP OF QUALITY OF WELL BEING AND ACUTE CHANGES IN DEPRESSION$0
M01 · FY2002 · RR
RELATIONSHIP OF QUALITY OF WELL BEING AND ACUTE CHANGES IN DEPRESSION$0
M01 · FY2002 · RR
RELATIONSHIP OF QUALITY OF WELL BEING AND ACUTE CHANGES IN DEPRESSION$0
M01 · FY2002 · RR
RELATIONSHIP OF QUALITY OF WELL BEING AND ACUTE CHANGES IN DEPRESSION$0
M01 · FY2001 · RR
RELATIONSHIP OF QUALITY OF WELL BEING AND ACUTE CHANGES IN DEPRESSION$0
M01 · FY2001 · RR
RELATIONSHIP OF QUALITY OF WELL BEING AND ACUTE CHANGES IN DEPRESSION$0
M01 · FY2000 · RR
RELATIONSHIP OF QUALITY OF WELL BEING AND ACUTE CHANGES IN DEPRESSION$0
M01 · FY2000 · RR
RELATIONSHIP OF QUALITY OF WELL BEING AND ACUTE CHANGES IN DEPRESSION$0
M01 · FY2000 · RR